Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Epstein-Barr Virus Infections 1

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Tegafur × Clear all
NCT01262274 2015-05-21

Neo-ACET BC

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Phase 2 Terminated
57 enrolled
Breast

Breast Neoplasms

NCT00005608 2012-06-06

Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer

Northwestern University

Phase 2 Terminated
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡